NCT05613569View on ClinicalTrials.gov

A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

Active, not recruitingOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

August 30, 2026

Study Completion Date

April 30, 2027

Conditions
Lumbosacral Radiculopathy
Interventions
DRUG

KLS-2031

KLS-2031 administered by transforaminal epidural injection

Trial Locations (1)

84107

Kolon Investigative Site : CenExel JBR, Salt Lake City

Sponsors

Lead Sponsor

Kolon Life Science
All Listed Sponsors
lead

Kolon Life Science

INDUSTRY